Editas Medicine(EDIT) - 2024 Q2 - Earnings Call Transcript

Editas Medicine, Inc. (NASDAQ:EDIT) Q2 2024 Results Conference Call August 7, 2024 8:00 AM ET Company Participants Cristi Barnett - Corporate Communications and Investor Relations Gilmore O’Neill - Chief Executive Officer Baisong Mei - Chief Medical Officer Erick Lucera - Chief Financial Officer Linda Burkly - Chief Scientific Officer Caren Deardorf - Chief Commercial and Strategy Officer Conference Call Participants Jack Allen - Baird Samantha Semenkow - Citi Eric Schmidt - Cantor Fitzgerald Terence Flynn ...